acetazolamide has been researched along with Leukemia, Myeloid, Acute in 3 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a case of pseudotumor cerebri associated with the administration of intermediate-dose cytarabine." | 7.70 | Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. ( Fort, JA; Smith, LD, 1999) |
| "To describe a case of pseudotumor cerebri associated with the administration of intermediate-dose cytarabine." | 3.70 | Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. ( Fort, JA; Smith, LD, 1999) |
| " The possible causes for this condition were starvation, parenteral glucose and saline administration, sepsis, hypokalemia and treatment with acetazolamide." | 3.66 | Life-threatening hypophosphatemia in a patient with acute myelogenous leukemia. ( Aderka, D; Berliner, S; Pinkhas, J; Santo, M; Shaklai, M; Shoenfeld, Y; Weinberger, A, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aderka, D | 1 |
| Shoenfeld, Y | 1 |
| Santo, M | 1 |
| Berliner, S | 1 |
| Shaklai, M | 1 |
| Weinberger, A | 1 |
| Pinkhas, J | 1 |
| Hanson, L | 1 |
| Morgan, HJ | 1 |
| Fort, JA | 1 |
| Smith, LD | 1 |
3 other studies available for acetazolamide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Life-threatening hypophosphatemia in a patient with acute myelogenous leukemia.
Topics: Acetazolamide; Cytarabine; Daunorubicin; Female; Glucose; Humans; Leukemia, Myeloid, Acute; Middle A | 1980 |
A young leukemic patient with headache.
Topics: Acetazolamide; Adult; Female; Headache; Humans; Leukemia, Myeloid, Acute; Pseudotumor Cerebri | 1993 |
Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.
Topics: Acetazolamide; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Child; Cytarabine; | 1999 |